These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21092444)
1. [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases]. Qi XK; Liu JG; Qian HR; Qiu F; Yao S; Li CQ; Wang YM Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):750-3. PubMed ID: 21092444 [TBL] [Abstract][Full Text] [Related]
2. [Clinical features and neuroimaging findings of 12 patients with acute disseminated encephalomyelitis involved in corpus callosum]. Liu JG; Qiao WY; Dong QW; Zhang HL; Zheng KH; Qian HR; Qi XK Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3036-41. PubMed ID: 23328373 [TBL] [Abstract][Full Text] [Related]
3. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center. Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455 [TBL] [Abstract][Full Text] [Related]
8. Multishot diffusion-weighted imaging features in spinal cord infarction. Zhang J; Huan Y; Qian Y; Sun L; Ge Y J Spinal Disord Tech; 2005 Jun; 18(3):277-82. PubMed ID: 15905774 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of pathological characteristics of acute and chronic cerebral tumefactive demyelinating lesions]. Sun C; Liu J; Gui Q; Lu D; Qi X Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(45):3557-61. PubMed ID: 25622833 [TBL] [Abstract][Full Text] [Related]
10. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670 [TBL] [Abstract][Full Text] [Related]
11. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721 [TBL] [Abstract][Full Text] [Related]
12. Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Saini J; Chatterjee S; Thomas B; Kesavadas C Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739 [TBL] [Abstract][Full Text] [Related]
17. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study. Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666 [TBL] [Abstract][Full Text] [Related]
18. MRI findings of eosinophilic myelomeningoencephalitis due to Angiostrongylus cantonensis. Jin E; Ma D; Liang Y; Ji A; Gan S Clin Radiol; 2005 Feb; 60(2):242-50. PubMed ID: 15664579 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924 [TBL] [Abstract][Full Text] [Related]
20. Clinical isolated syndrome: a 3-year follow-up study in China. Liu Y; Duan Y; Yu C; Qin W; Chen H; Dong H; Ye J; Butzkueven H; Li K Clin Neurol Neurosurg; 2011 Oct; 113(8):658-60. PubMed ID: 21680087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]